No Data
Sector Update: Health Care Stocks Edge Higher in Afternoon Trading
Health care stocks were edging up Friday afternoon, with the NYSE Health Care Index rising 0.2% and the Health Care Select Sector SPDR Fund (XLV) up less than 0.1%. The iShares Biotechnology ETF (IBB)
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $40 Price Target
HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus (NASDAQ:AGEN) with a Buy and maintains $40 price target.
Agenus Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 177.39% HC Wainwright & Co. $40 → $40 Reiterates Buy → Buy 05/24/2024 177.39% HC Wainwright & C
Agenus Shares Rise 12% After Positive Data From Botensilimab/Balstilimab Study
By Chris Wack Agenus shares were up 12% to $15.86 after the company said it saw positive results from an investigator-sponsored trial of botensilimab and balstilimab in the neoadjuvant setting for co
Agenus Shares Rise After Trial Shows Tumor Reductions in Colon Cancer Patients
Agenus (AGEN) shares were up more than 6% in recent Friday trading after the company posted results from an investigator-sponsored trial of botensilimab and balstilimab in the neoadjuvant setting for
Agenus Announces Extended BOT/BAL Therapy Yields Pronounced Tumor Reductions In Colon Cancer; Results From Investigator-Sponsored Trial Presented At 2024 ESMO Gastrointestinal Cancers Congress
Agenus Announces Extended BOT/BAL Therapy Yields Pronounced Tumor Reductions In Colon Cancer; Results From Investigator-Sponsored Trial Presented At 2024 ESMO Gastrointestinal Cancers Congress